Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats
Anxiety disorders are one of the most common mental disorders, and benzodiazepines (BDZs), acting on gamma-aminobutyric acid type A (GABA-A) receptor complex, represent the most common antianxiety medications in the world. However, chronic BDZ use elicits several adverse reactions. Reportedly, aroma...
Main Authors: | Laura Rombolà, Damiana Scuteri, Annagrazia Adornetto, Marilisa Straface, Tsukasa Sakurada, Shinobu Sakurada, Hirokazu Mizoguchi, Maria Tiziana Corasaniti, Giacinto Bagetta, Paolo Tonin, Luigi Antonio Morrone |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/2156873 |
Similar Items
-
Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent
by: Laura Rombolà, et al.
Published: (2020-04-01) -
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach
by: Damiana Scuteri, et al.
Published: (2019-07-01) -
Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia
by: Damiana Scuteri, et al.
Published: (2021-03-01) -
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation
by: Kengo Hamamura, et al.
Published: (2020-08-01) -
Efficacy of Essential Oils in Pain: A Systematic Review and Meta-Analysis of Preclinical Evidence
by: Damiana Scuteri, et al.
Published: (2021-03-01)